Answers are grounded in this paper and cite their sources.
The efficacy of a 4-month rifapentine-based regimen containing moxifloxacin was noninferior to the standard 6-month regimen in the treatment of tuberculosis. (Funded by the Centers for Disease Control and Prevention and others; Study 31/A5349 ClinicalTrials.gov number, NCT02410772.).
No takes yet. Share an insight, caveat, or question.
Dorman et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: